VS Peps
← Back to Tirzepatide

VS Peps · Certificate № JN-260522-8839

Certificate of Analysis

Compound identity

TZP

Tirzepatide

GLP-1 / GIP dual agonist · 10mg lyophilized

Batch identifiers

Batch IDJN-260522-8839
Lab referenceLR-20263
Test date2026-05-22
Format10mg · lyophilized

HPLC Analysis

High-Performance Liquid Chromatography

Reported purity

99.4%

Area under the target peak as a percentage of total area.

Batch · 2026-05-22Janoshik Analytical · HPLC
99.4%TZP2 MIN5 MIN8 MIN12 MIN

Identity verification

Compound nameTirzepatide
Editorial codeTZP
Molecular formConfirmed by MS
Test methodRP-HPLC / UV-Vis
Reference standardIn-house standard, characterized
Storage at testLyophilized, sealed vial, RT

Structure

39residues
3-letter notation

39-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01Aib substitutions at positions 2 and 13
  • 02C20 fatty diacid sidechain via γ-Glu linker

Sourcing & storage

Sourcing chain

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & handling

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 28 days. Research use only.

Lab analyst signature

Janoshik Analytical

Verified · 2026-05-22

Document control

Certificate № JN-260522-8839Issued 2026-05-22Format RP-HPLC / UVDistribution Per-product page

Research use only. This certificate documents analytical results for the batch identified above. Products are sold strictly for laboratory and research applications and are not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. The information herein is provided in good faith based on third-party HPLC analysis but is not a guarantee or warranty. See Research Use Disclaimer for full terms.